GENEVA, July 1 -- SOLVE THERAPEUTICS, INC. filed a patent application (US2025/036490) for “ANTI-ROR2 ANTIBODY-RADIONUCLIDE CONJUGATES”. With publication no. WO/2026/128025, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 51/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....